Concepedia

Peter Vaillancourt

PV

Statistics

Publications

17

Citations

1.2K

H-Index

14

Active since

1983

Affiliations

Eli Lilly (United States)(Current)

National Institute of Allergy and Infectious Diseases

University of California, Berkeley

Torrey Pines Institute For Molecular Studies

Peter Vaillancourt is an author at Eli Lilly (United States) specializing in life sciences, molecular biology, and antibody characterization.

Publications per year

1983–2022

17

Publications

17

LY-CoV1404 (bebtelovimab) potently neutralizes SARS-CoV-2 variants

Kathryn Westendorf, Stefanie Žentelis, Lingshu Wang et al. · Cell Reports · 2022 · 464 citations · Full text

Pharmacy, Infectious Diseases, Pharmacology +17

Bovine papillomavirus type 1 encodes two forms of a transcriptional repressor: structural and functional analysis of new viral cDNAs

Joonho Choe, Peter Vaillancourt, Arne Stenlund et al. · Journal of Virology · 1989 · 130 citations · Full text

Life Sciences, Genetics, Molecular Biology +17

LY2875358, a Neutralizing and Internalizing Anti-MET Bivalent Antibody, Inhibits HGF-Dependent and HGF-Independent MET Activation and Tumor Growth

Ling Liu, Wei Zeng, Mark A. Wortinger et al. · Clinical Cancer Research · 2014 · 109 citations

Medicine, Cancer Biology, Oncology +15

Development and validation of an antibody-dependent cell-mediated cytotoxicity-reporter gene assay

Bhavin S. Parekh, E. Berger, Sharon Sibley et al. · mAbs · 2012 · 101 citations · Full text

Pharmacy, Immunology, Oncology +17

A new expression vector for high level protein production, one step purification and direct isotopic labeling of calmodulin-binding peptide fusion proteins

Chaofeng Zheng, Timothy G. Simcox, Li Xu et al. · Gene · 1997 · 60 citations

Life Sciences, Biochemistry, Biotechnology +16

1–5 of 17